papaverinum-injeel liq liquid
biologische heilmittel heel gmbh - papaverine; papaverine; papaverine - liquid - 12d; 30d; 200d - papaverine 12d; papaverine 30d; papaverine 200d - homeopathic products
tracrium atracurium besilate 25mg/2.5ml injection ampoule
aspen pharmacare australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; benzenesulfonic acid - tracrium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.
tracrium atacurium besilate 50mg/5ml injection ampoules
aspen pharmacare australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - tracrium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.
dbl papaverine hydrochloride
hospira australia pty ltd - papaverine hydrochloride -
movapo apomorphine hydrochloride hemihydrate 50 mg/5 ml injection ampoule
stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.
movapo apomorphine hydrochloride hemihydrate 20 mg/2ml injection ampoule
stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 20 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.
niopam 340 solution for injection 50ml bottles
bracco uk ltd - iopamidol - solution for injection - 340mg/1ml
niopam 340 solution for injection 70ml bottles
bracco uk ltd - iopamidol - solution for injection - 340mg/1ml
niopam 340 solution for injection 100ml bottles
bracco uk ltd - iopamidol - solution for injection - 340mg/1ml
niopam 340 solution for injection 200ml bottles
bracco uk ltd - iopamidol - solution for injection - 340mg/1ml